FAT1 and Hepatic steatosis: Although fenofibrate can also reduce blood lipids and improve fatty liver, it is less effective than Fat-1 in improving HDL-C levels and NEFA levels, as well as optimizing plasma apolipoprotein levels and lipoprotein distribution.